N
Nemis Technologies
Developing diagnostic kits and solutions for accelerated microbiological detection
About Nemis Technologies
NEMIS Technologies AG is a pioneering biotech startup specializing in the development of innovative diagnostic kits that leverage chemiluminescence technology to address critical issues in microbiology. The company primarily serves the food safety and healthcare sectors, focusing on detecting foodborne pathogens and combating antimicrobial resistance. Operating in the biotechnology market, NEMIS Technologies employs a B2B business model, targeting food producers, healthcare providers, and laboratories as its main clients. The company generates revenue through the sale of its diagnostic kits and related services. By integrating advanced chemiluminescence technology, NEMIS Technologies offers a unique value proposition that enhances the accuracy and speed of microbial detection, thereby improving public health outcomes.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Zurich, Switzerland
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
SICTIC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nemis Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nemis Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.